Recent news on Teriparatide

EU drug panel doesn't back Amgen's Vectibix for colon cancer  -  25 May 2007
MarketWatchForsteo (teriparatide), from Eli Lilly Nederland BV, to extend the indication to include treatment of osteoporosis in men. Furthermore, the indication has

Adult Hypophosphatasia Treated with Teriparatide  -  Apr 4, 2007
Journal of Clinical Endocrinology and Metabolism,Teriparatide (TPTD) (recombinant human PTH 1–34), 20 µg, was injected sc daily in an attempt to enhance osteoblast synthesis of TNSALP.

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Earthtimes.orgLilly) Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin

Amgen's Upcoming RANKL Inhibitor Denosumab Will Become the ...  -  Mar 26, 2007
Drug Newswire (press release),...replace Eli Lilly's Forteo as the clinical gold-standard therapy because of its improved safety and more convenient delivery relative to teriparatide.

Amgen's Upcoming RANKL Inhibitor Denosumab Will Become the ...  -  Mar 6, 2007
PharmaLive.com (press release),...replace Eli Lilly's Forteo as the clinical gold-standard therapy because of its improved safety and more convenient delivery relative to teriparatide.

Cymbalta is bright spot as charges batter Lilly net income  -  Feb 1, 2007
Pharma Times (subscription),The osteoporosis drug Forteo (teriparatide), US sales of which significantly benefited from access to medical coverage through the Medicare Part D programme

Zelos: osteoporosis therapy to face challenge despite positive data  -  Feb 9, 2007
Pharmaceutical Business ReviewEli Lilly's Forteo (teriparatide) was the first drug to be marketed in this class; for the treatment of postmenopausal osteoporosis in women and in men with

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.orgICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin injection, Lilly) Gemzar® (gemcitabine hydrochloride,

Alendronate impairs the action of Teriparatide to increase bone ...  -  Dec 23, 2006
Xagena.it,Researchers have evaluated whether Teriparatide increases osteoblast activity when the ability of Teriparatide to increase osteoclast activity is suppressed

Ontario government invests in bone health  -  Jan 10, 2007
CNW Telbec (Communiqués de presse),Bisphosphonates and teriparatide for the prevention of osteoporotic fractures in postmenopausal women (Technology overview no 22).

Alendronate impairs the action of Teriparatide to increase bone ...  -  Dec 23, 2006
Xagena.it,Researchers have evaluated whether Teriparatide increases osteoblast activity when the ability of Teriparatide to increase osteoclast activity is suppressed

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),...cancer treatment Alimta (pemextred) and Forteo (teriparatide) for osteporosis, while sales of the company's biggest product, the antipsychotic Zyprexa

Nastech delays osteoporosis nasal spray development  -  Dec 6, 2006
DrugResearcher.com,Eli Lilly is already a player in the osteoporosis market and has already launched a drug – Forteo (teriparatide) – to treat the condition that is delivered

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin, Lilly) Gemzar(R) (gemcitabine hydrochloride,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional